GB9320316D0 - Pharmaceuticals - Google Patents

Pharmaceuticals

Info

Publication number
GB9320316D0
GB9320316D0 GB939320316A GB9320316A GB9320316D0 GB 9320316 D0 GB9320316 D0 GB 9320316D0 GB 939320316 A GB939320316 A GB 939320316A GB 9320316 A GB9320316 A GB 9320316A GB 9320316 D0 GB9320316 D0 GB 9320316D0
Authority
GB
United Kingdom
Prior art keywords
pharmaceuticals
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GB939320316A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Priority to GB939320316A priority Critical patent/GB9320316D0/en
Publication of GB9320316D0 publication Critical patent/GB9320316D0/en
Priority to PCT/EP1994/003219 priority patent/WO1995009855A1/en
Pending legal-status Critical Current

Links

GB939320316A 1993-10-01 1993-10-01 Pharmaceuticals Pending GB9320316D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB939320316A GB9320316D0 (en) 1993-10-01 1993-10-01 Pharmaceuticals
PCT/EP1994/003219 WO1995009855A1 (en) 1993-10-01 1994-09-26 Amino acids esters of penciclovir and brl 44385

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB939320316A GB9320316D0 (en) 1993-10-01 1993-10-01 Pharmaceuticals

Publications (1)

Publication Number Publication Date
GB9320316D0 true GB9320316D0 (en) 1993-11-17

Family

ID=10742881

Family Applications (1)

Application Number Title Priority Date Filing Date
GB939320316A Pending GB9320316D0 (en) 1993-10-01 1993-10-01 Pharmaceuticals

Country Status (2)

Country Link
GB (1) GB9320316D0 (en)
WO (1) WO1995009855A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5994361A (en) * 1994-06-22 1999-11-30 Biochem Pharma Substituted purinyl derivatives with immunomodulating activity
JP4097698B2 (en) * 1996-01-19 2008-06-11 グラクソ、グループ、リミテッド Use of valaciclovir for the manufacture of a medicament for the treatment of genital herpes by administration once a day
US6703394B2 (en) 1996-02-16 2004-03-09 Medivir Ab Acyclic nucleoside derivatives
US5869493A (en) * 1996-02-16 1999-02-09 Medivir Ab Acyclic nucleoside derivatives
AU1711599A (en) * 1997-12-19 1999-07-12 Bristol-Myers Squibb Company Prodrugs of lobucavir and methods of use
CN101033238B (en) * 2006-03-06 2011-02-16 中国科学院上海药物研究所 Preparation method and use for purine compounds double amino acid ester

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57142998A (en) * 1981-02-27 1982-09-03 Fuji Kagaku Kogyo Kk Novel 5-fluorouridine derivative and its preparation
EP0080305A1 (en) * 1981-11-19 1983-06-01 Beecham Group Plc Antiviral 2'-deoxyuridines, their preparation and use
NL8202626A (en) * 1982-06-29 1984-01-16 Stichting Rega V Z W DERIVATIVES OF 9- (2-HYDROXYETHOXYMETHYL) GUANINE.
AP55A (en) * 1987-08-15 1989-09-26 The Wellcome Foundation Ltd Therapeutic Acyclic Nucleosides
EP0366385B1 (en) * 1988-10-24 1993-06-09 The Wellcome Foundation Limited Guanine derivatives having antiviral activity and their pharmaceutically acceptable salts
GB8829571D0 (en) * 1988-12-19 1989-02-08 Wellcome Found Antiviral compounds
US5043339A (en) * 1988-12-19 1991-08-27 Burroughs Wellcome Co. Antiviral compounds
NZ250842A (en) * 1991-02-22 1996-03-26 Univ Emory Resolution of a racemic mixture of nucleoside enantiomers such as 2-hydroxymethyl-5-(5-fluorocytosin-1-yl)-1,3-oxathiolane (ftc)

Also Published As

Publication number Publication date
WO1995009855A1 (en) 1995-04-13

Similar Documents

Publication Publication Date Title
SG50693A1 (en) Pharmaceuticals
GB9301660D0 (en) Pharmaceuticals
AP9400626A0 (en) Pharmaceuticals
GB9312348D0 (en) Pharmaceuticals
GB9321811D0 (en) Pharmaceuticals
GB9321812D0 (en) Pharmaceuticals
GB9320316D0 (en) Pharmaceuticals
AP9400684A0 (en) Pharmaceuticals
GB9303340D0 (en) Pharmaceuticals
GB9326177D0 (en) Pharmaceuticals
GB9321394D0 (en) Pharmaceuticals
GB9322395D0 (en) Pharmaceuticals
GB9316875D0 (en) Pharmaceuticals
GB9309643D0 (en) Pharmaceuticals
GB9320770D0 (en) Pharmaceuticals
GB9326036D0 (en) Pharmaceuticals
GB9325617D0 (en) Pharmaceuticals
GB9322542D0 (en) Pharmaceuticals
GB9322416D0 (en) Pharmaceuticals
GB9310776D0 (en) Pharmaceuticals
GB9322394D0 (en) Pharmaceuticals
GB9309642D0 (en) Pharmaceuticals
GB9307126D0 (en) Pharmaceuticals
GB9306016D0 (en) Pharmaceuticals
GB9305155D0 (en) Pharmaceuticals